Related Experiment Video

Updated: Oct 3, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Management of neonatal hyperbilirubinaemia and prevention of kernicterus

F F Rubaltelli1, P F Griffith

  • 1Department of Paediatrics, University of Padova, Italy.

Drugs
|June 1, 1992
PubMed

Insights

Neonatal hyperbilirubinaemia, a common newborn condition, poses risks like bilirubin encephalopathy in premature infants. Tin-protoporphyrin shows promise as a safe, cost-effective treatment for jaundice.

Area of Science:

  • Neonatology
  • Biochemistry

Background:

  • Neonatal hyperbilirubinaemia is a prevalent pathological condition in newborns.
  • Premature infants are particularly susceptible to developing severe jaundice and potential bilirubin encephalopathy, even with lower serum bilirubin levels.

Purpose of the Study:

  • To review current management strategies for severe neonatal jaundice.
  • To explore the potential of tin-protoporphyrin as a novel therapeutic agent for neonatal hyperbilirubinaemia.

Main Methods:

  • Review of existing treatments for neonatal jaundice, including phenobarbital, phototherapy, and exchange transfusion.
  • Discussion of the emerging role and potential of tin-protoporphyrin in managing hyperbilirubinaemia.

Main Results:

  • Established treatments for neonatal jaundice include pharmacologic induction of liver enzymes, phototherapy, and exchange transfusion.
  • Tin-protoporphyrin is currently under investigation and not yet approved for clinical use.

Conclusions:

  • Further research is needed to establish the safety and efficacy of tin-protoporphyrin.
  • If proven safe and cost-effective, tin-protoporphyrin could significantly advance the treatment of neonatal jaundice.

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...